Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that it has entered into an agreement with LENSAR, Inc. (NASDAQ: LNSR) to terminate the...
Milestone includes more than 6 million PCIOL implants worldwide, with PanOptix and Vivity leading globally in trifocal and EDOF IOLs 1,* ...
Fourth-quarter 2025 sales of $2.7 billion, up 9% on a reported basis, or up 7% constant currency 1 (cc), versus fourth-quarter 2024 ...
Provides excellent end of day comfort even on day 30, ^ helping patients stay in contact lenses † comfortably...
PRECISION7, a new one-week replacement lens, provides 16 hours of outstanding comfort and precise vision even on day 7 1 ...
Alcon Inc., the global leader in eye care dedicated to helping people see brilliantly, today announced the completion of its $750 million share repurchase program, which commenced on April 1, 2025. ...
Ad hoc announcement pursuant to Art. 53 LR
Thanks Fellow Shareholders for Rejecting the Transaction Reiterates Enthusiasm for the Company’s Standalone Prospects ...
Alcon (SIX/NYSE: ALC) CEO David Endicott will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 a.m. PST. A live webcast of the conference will...
Urges Board to Allow Shareholders to Have Their Final Say on This Ill-Conceived Transaction